Actinic keratoses (also known as solar keratoses or sun spots) refers to the development of abnormal skin cells, due to exposure to ultraviolet radiation. They are considered pre-cancerous or an early form of squamous cell carcinoma.

At The Skin Centre, we currently have two trials being conducted for Actinic Keratoses. We are not recruiting for trial LP0041-62, but are still accepting patients for LP0105-1020. If you have interest in this trial, please contact us.

LP0041-62 (not recruiting)

This trial aims to achieve histological confirmation of clinical clearance of actinic keratoses following treatment with Ingenol Mebutate Gel 0.05%(Picato)-LP0041-62.

This is a phase 1, multicentre, single-arm, open label trial, that is conducted over eight weeks. 

This trial is full, and therefore we are not taking any further applicants. 

LP0105-1020 (Recruiting)

This trial is being conducted to determine the efficacy and safety of Ingenol Mebutate gel 0.06% (Picato), when applied once daily for two, three or four consecutive days to a treatment area of approximately 250cm2 on the trunk and extremities in subjects with actinic keratosis. 

LP0105-1020 is an international, phase 2, randomised, multicentre, double-blind and vehicle-controlled trial that is conducted over an eight week period. 

If you are interested in participating, please contact our Clinical Trials Manager today. 

Contact us using the form below if you want to participate in these clinical trials

Fact Sheets